Analystreport

VERONA PHARMA P/S (NASDAQ: VRNA) had its "buy" rating re-affirmed by analysts at Wedbush.

Verona Pharma plc - American Depositary Shares  (VRNA) 
US:NASDAQ Investor Relations: nasdaq.com/symbol/vrna/real-time